New frontiers in Parkinson’s disease

© 2026 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )

Download PDF

XML

Cite

Conflict of interest

The author declares no competing interests.

References

Grossauer A, Hemicker G, Krismer F, et al. α‐Synuclein seed amplification assays in the diagnosis of synucleinopathies using cerebrospinal fluid—a systematic review and meta‐analysis. Movement Disord Clin Pract. 2023;10(5):737-747. doi: 10.1002/mdc3.13710
Höglinger GU, Adler CH, Berg D, et al. A biological classification of Parkinson’s disease: the SynNeurGe research diagnostic criteria. Lancet Neurol. 2024;23(2):191-204. doi: 10.1016/s1474-4422(23)00404-0
Jiang C, Hopfner F, Katsikoudi A, et al. Serum neuronal exosomes predict and differentiate Parkinson’s disease from atypical parkinsonism. J Neurol Neurosurg Psychiatry. 2020;91(7):720-729. doi: 10.1136/jnnp-2019-322588
Zhou G, Ren J, Rong D, et al. Monitoring substantia nigra degeneration using free water imaging across prodromal and clinical Parkinson’s disease. Mov Disord. 2023;38(5):774-782. doi: 10.1002/mds.29366
Sapienza S, Tsurkalenko O, Giraitis M, et al. Assessing the clinical utility of inertial sensors for home monitoring in Parkinson’s disease: a comprehensive review. npj Parkinsons Dis. 2024;10(1). doi: 10.1038/s41531-024-00755-6
Kim TY, Lee BD. Current therapeutic strategies in Parkinson’s disease: Future perspectives. Mol Cells 2025;48(11):100274.doi: 10.1016/j.mocell.2025.100274

Previous article in this issue

Next article in this issue

Advanced Neurology, Electronic ISSN: 2810-9619 Print ISSN: 3060-8589, Published by AccScience Publishing